Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Targeted Precision Nutrition Strategy to Ensure Age-specific Protein Requirements: a Multicenter Cross-sectional Observational Study (OPTIPROT)
Authors not listed
Fundació Eurecat · 2024
Abstract
This multicenter, cross-sectional observational study aims to use precision nutrition tools to identify metabolic clusters in adults aged 50-75 years, enabling tailored nutritional and protein recommendations based on specific metabolic characteristics. Conducted at Eurecat-Reus (Catalonia) and AZTI (Bizkaia), the study will enroll 200 participants (75 at Eurecat, 125 at AZTI). Analyses will include metabolomics, gut microbiota profiling, epigenomics, and glycomics, with the goal of refining dietary guidelines and protein intake recommendations to address the specific needs of aging populations.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Anonymous. (2024). Targeted Precision Nutrition Strategy to Ensure Age-specific Protein Requirements: a Multicenter Cross-sectional Observational Study (OPTIPROT). <em>Fundació Eurecat</em>. https://clinicaltrials.gov/study/NCT07436936
Vancouver
Anonymous. Targeted Precision Nutrition Strategy to Ensure Age-specific Protein Requirements: a Multicenter Cross-sectional Observational Study (OPTIPROT). Fundació Eurecat. 2024.
BibTeX
@misc{anon2024Target,
title = {Targeted Precision Nutrition Strategy to Ensure Age-specific Protein Requirements: a Multicenter Cross-sectional Observational Study (OPTIPROT)},
author = {Anonymous},
journal = {Fundació Eurecat},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging 2010
Open access · CC-BY
Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice
Merck Sharp & Dohme LLC 2010
Open access · US-GOV
A Non-interventional Cohort Study for the Assessment of the Efficacy of RALTEGRAVIR 400 mg Administered Twice Daily in Combination With Other Antiretroviral Drugs to Treat Infection With the Human Immunodeficiency Virus 1 (HIV-1) in Adults and Aging Patients (≥ 50 Years) Under Conditions That Are Representative of the Nationwide Treatment of HIV-positive Patients in Germany
Insel Gruppe AG, University Hospital Bern 2024
Open access · US-GOV
PrEcision Medicine in the Management of Cardiovascular Surgery Associated AKI - PEAK: a Prospective Observational Cohort Study
PLoS Medicine 2024
Open access · CC-BY
Development, characterization, and replication of proteomic aging clocks: Analysis of 2 population-based cohorts
Scientific Reports 2024
Open access · CC-BY
Inverted U-shaped relationship between sleep duration and phenotypic age in US adults: a population-based study
University Hospital, Clermont-Ferrand 2011
Open access · US-GOV